Cargando…
A retrospective ‘real-world’ cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis
BACKGROUND: Individuals with cystic fibrosis (CF) have an increased susceptibility to fungal infection/allergy, with triazoles often used as first-line therapy. Therapeutic drug monitoring (TDM) is essential due to significant pharmacokinetic variability and the recent emergence of triazole resistan...
Autores principales: | Di Paolo, M, Hewitt, L, Nwankwo, E, Ni, M, Vidal-Diaz, A, Fisher, M C, Armstrong-James, D, Shah, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210303/ https://www.ncbi.nlm.nih.gov/pubmed/34223100 http://dx.doi.org/10.1093/jacamr/dlab026 |
Ejemplares similares
-
Erratum to: A retrospective ‘real-world’ cohort study of azole therapeutic drug monitoring and evolution of antifungal resistance in cystic fibrosis
por: Di Paolo, M, et al.
Publicado: (2021) -
Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy
por: Burgel, Pierre-Régis, et al.
Publicado: (2016) -
New Antifungal Agents with Azole Moieties
por: Teixeira, Melissa Martins, et al.
Publicado: (2022) -
Experimental Evolution of Multidrug Resistance in Neurospora crassa under Antifungal Azole Stress
por: Zhou, Mi, et al.
Publicado: (2022) -
Recommendations on the use of azole antifungals in hematology-oncology patients
por: Azanza, José Ramón, et al.
Publicado: (2023)